BBLG · Bone Biologics Corporation

Summary

Bone Biologics Corporation filed a prospectus supplement with the U.S. Securities and Exchange Commission on March 13, 2026. The filing includes exhibits consisting of an opinion and consent from Harter Secrest & Emery LLP.

Key takeaways

• Filed prospectus supplement on 2026-03-13
• Exhibit 5.1: Opinion of Harter Secrest & Emery LLP
• Exhibit 23.1: Consent of Harter Secrest & Emery LLP